Ulpiano Flores, Author at Converge Consulting

By Ulpiano Flores|2023-02-07T13:24:28-05:0002/07/2023|

Minimizing COI & COC Risk 3 Essential Components for Autologous Cell Therapy Facilities Originally Published as a MassBio Guest Blog Autologous cell therapies involve collecting and processing a patient’s own cells, and later administering the processed cells back into the body to treat the same patient. The personalized nature of these [...]

Event Recap: 2022 & Beyond – Serialization Requirements for Manufacturers

By Ulpiano Flores|2022-11-14T11:53:27-05:0010/25/2022|

Event Recap: 2022 & Beyond - Serialization Requirements for Manufacturers To ensure product safety, the Drug Supply Chain Security Act (DSCSA) requires pharmaceutical trading partners to share data that tracks product movement and traceability through the supply chain. The sharing of data is dependent on the Electronic Product Code Information System (EPCIS). Although [...]

About Ulpiano Flores

Minimizing COI & COC Risk

Event Recap: 2022 & Beyond – Serialization Requirements for Manufacturers